These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 16380519)
41. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications. Kim MJ; Kim SY; Park SY; Ahn HK; Chung JH; Ryu HM Placenta; 2013 Jan; 34(1):57-61. PubMed ID: 23187089 [TBL] [Abstract][Full Text] [Related]
42. The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction. Kovo M; Schreiber L; Ben-Haroush A; Gold E; Golan A; Bar J Prenat Diagn; 2012 Jul; 32(7):632-7. PubMed ID: 22565848 [TBL] [Abstract][Full Text] [Related]
43. Soluble CD30 in normotensive pregnant women with isolated fetal intrauterine growth restriction: a comparison with preeclamptic women. Laskowska M; Laskowska K; Oleszczuk J J Reprod Immunol; 2010 Nov; 86(2):122-5. PubMed ID: 20591497 [TBL] [Abstract][Full Text] [Related]
44. beta-globin DNA in maternal plasma as a molecular marker of pre-eclampsia. Sekizawa A; Farina A; Koide K; Iwasaki M; Honma S; Ichizuka K; Saito H; Okai T Prenat Diagn; 2004 Sep; 24(9):697-700. PubMed ID: 15386451 [TBL] [Abstract][Full Text] [Related]
45. Plasma vasopressin, oxytocin, estradiol, and progesterone related to water and sodium excretion in normal pregnancy and gestational hypertension. Risberg A; Olsson K; Lyrenas S; Sjöquist M Acta Obstet Gynecol Scand; 2009; 88(6):639-46. PubMed ID: 19412798 [TBL] [Abstract][Full Text] [Related]
46. Placental apoptosis and adhesion molecules expression in the placenta and the maternal placental bed of pregnancies complicated by fetal growth restriction with and without pre-eclampsia. Madazli R; Benian A; Ilvan S; Calay Z J Obstet Gynaecol; 2006 Jan; 26(1):5-10. PubMed ID: 16390700 [TBL] [Abstract][Full Text] [Related]
47. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation. Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266 [TBL] [Abstract][Full Text] [Related]
48. Reduced red blood cell deformability, an indicator for high fetal or maternal risk, is found in preeclampsia and IUGR. Schauf B; Lang U; Stute P; Schneider S; Dietz K; Aydeniz B; Wallwiener D Hypertens Pregnancy; 2002; 21(2):147-60. PubMed ID: 12175443 [TBL] [Abstract][Full Text] [Related]
49. Maternal and fetal fatty acid profile in normal and intrauterine growth restriction pregnancies with and without preeclampsia. Alvino G; Cozzi V; Radaelli T; Ortega H; Herrera E; Cetin I Pediatr Res; 2008 Dec; 64(6):615-20. PubMed ID: 19034199 [TBL] [Abstract][Full Text] [Related]
50. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. Egbor M; Ansari T; Morris N; Green CJ; Sibbons PD BJOG; 2006 May; 113(5):580-9. PubMed ID: 16579806 [TBL] [Abstract][Full Text] [Related]
51. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Schjetlein R; Abdelnoor M; Haugen G; Husby H; Sandset PM; Wisløff F Acta Obstet Gynecol Scand; 1999 Mar; 78(3):191-7. PubMed ID: 10078579 [TBL] [Abstract][Full Text] [Related]
52. Maternal hemodynamics in normal pregnancy and in pregnancy affected by pre-eclampsia. Stott D; Nzelu O; Nicolaides KH; Kametas NA Ultrasound Obstet Gynecol; 2018 Sep; 52(3):359-364. PubMed ID: 28796394 [TBL] [Abstract][Full Text] [Related]
53. Characterization of fetal monocytes in preeclampsia and fetal growth restriction. Alahakoon TI; Medbury H; Williams H; Fewings N; Wang XM; Lee VW J Perinat Med; 2019 May; 47(4):434-438. PubMed ID: 30822277 [TBL] [Abstract][Full Text] [Related]
54. The "weight" of fetal growth restriction in 437 hypertensive pregnancies. Tranquilli AL; Giannubilo SR Arch Gynecol Obstet; 2004 Dec; 270(4):214-6. PubMed ID: 12942263 [TBL] [Abstract][Full Text] [Related]
55. Alterations of maternal plasma HTRA1 level in preeclampsia complicated by IUGR. Marzioni D; Lorenzi T; Altobelli E; Giannubilo SR; Paolinelli F; Tersigni C; Crescimanno C; Monsurrò V; Tranquilli AL; Di Simone N; Castellucci M Placenta; 2012 Dec; 33(12):1036-8. PubMed ID: 23083999 [TBL] [Abstract][Full Text] [Related]
56. Levels of neopterin and C-reactive protein in pregnant women with fetal growth restriction. Erkenekli K; Keskin U; Uysal B; Kurt YG; Sadir S; Çayci T; Ergün A; Erkaya S; Danişman N; Uygur D J Obstet Gynaecol; 2015 Apr; 35(3):225-8. PubMed ID: 25140392 [TBL] [Abstract][Full Text] [Related]
57. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219 [TBL] [Abstract][Full Text] [Related]
58. [Sex-hormone binding globulin (SHBG) levels during pregnancy as predictors for pre-eclampsia and fetal growth restriction]. Valdés R E; Lattes A K; Muñoz S H; Cumsille MA Rev Med Chil; 2012 May; 140(5):589-94. PubMed ID: 23096663 [TBL] [Abstract][Full Text] [Related]
59. Relationship between second-trimester amniotic fluid and plasma levels of angiopoietin-2 and thrombomodulin with adverse pregnancy outcome. Yener C; Varol F; Inan C; Sütcü H; Ateş S; Sayin C J Obstet Gynaecol; 2022 Jul; 42(5):923-928. PubMed ID: 34693872 [TBL] [Abstract][Full Text] [Related]
60. Methemoglobin levels in umbilical cord blood of women with intrauterine growth restriction and preeclampsia. Yusuf K; Wilson RD; Kamaluddeen M; Franta J; Hasan SU; Akierman A J Matern Fetal Neonatal Med; 2014 May; 27(8):789-94. PubMed ID: 23998850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]